Literature DB >> 4279253

Discrepancies between immunological and caseinolytic plasma plasminogen assays in health and hyperfibrinolytic states.

V Musumeci, G Leone, B Bizzi.   

Abstract

A sensitive immunological assay for plasminogen and/or plasmin was developed by using a haemagglutination inhibition technique. Plasma and the corresponding euglobulin fraction of healthy subjects and of patients with hyperfibrinolysis (liver cirrhosis, thrombolytic treatment) were assayed for plasminogen using immunological and caseinolytic techniques. In hyperfibrinolytic states discrepancies were found between immunoreactive and caseinolytic plasma plasminogen whereas a good correlation was observed between immunoreactive and caseinolytic euglobulin plasminogen. Experiments in vitro suggested that these discrepancies might depend on the presence in hyperfibrinolytic plasma of variable amounts of plasmin(ogen)-related antigen which has no caseinolytic activity and is not precipitated with euglobulin.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4279253      PMCID: PMC475484          DOI: 10.1136/jcp.27.10.794

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968.

Authors:  A J Johnson; D L Kline; N Alkjaersig
Journal:  Thromb Diath Haemorrh       Date:  1969-04-30

2.  Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.

Authors:  P C Harpel; M W Mosesson
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

3.  Radioimmunoassay of human plasminogen and plasmin.

Authors:  S F Rabiner; I D Goldfine; A Hart; L Summaria; K C Robbins
Journal:  J Lab Clin Med       Date:  1969-08

4.  Highly sensitive method for the assay of plasminogen.

Authors:  K K Wu; C D Jacobsen; J C Hoak
Journal:  J Lab Clin Med       Date:  1973-03

5.  Plasminogen assay by a haemagglutination inhibition technique.

Authors:  C A Ludlam; P C Das
Journal:  J Clin Pathol       Date:  1971-03       Impact factor: 3.411

6.  Methodological study and a recommended technique for determining the euglobulin lysis time.

Authors:  R Chakrabarti; M Bielawiec; J F Evans; G R Fearnley
Journal:  J Clin Pathol       Date:  1968-11       Impact factor: 3.411

7.  Immunochemical determination of human plasminogen.

Authors:  P O Ganrot; J E Niléhn
Journal:  Clin Chim Acta       Date:  1968-11       Impact factor: 3.786

8.  A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.

Authors:  C Merskey; P Lalezari; A J Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

9.  An improved fibrin plate method for the assay of plasminogen activators.

Authors:  P L Walton
Journal:  Clin Chim Acta       Date:  1966-05       Impact factor: 3.786

10.  Enzymatic and immunochemical determination of plasminogen and plasmin in different physiological and pathological states.

Authors:  P M Mannucci; R Stabilini; R Bragotti; B Marasini; A Agostoni
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.